Interested in taking part?

If you are interested in taking part, or want to find out more information, please contact the nearest site below.

Can I take part?

You may be eligible if: 

• Your glioblastoma has recurred (size of the recurrent tumor is important for eligibility, please discuss with your doctor)
  
  
• You are 18 years old or older
  
  
• Able to attend weekly visits at one of the locations (travel/accommodation may be paid) 
  
  
• Able to undergo CT and MRI scans
  
  
• You have not been treated with Carmustine or Gliadel® wafers.

A full assessment of eligibility will occur, if after speaking to a site, you are deemed suitable for screening. 

Where is the MAGIC-G1 trial taking place?

Currently only open for enrollment within the United States.

Email: Darlene.Brabant@bmcjax.com

Phone: +1 904-202-7332

Baptist MD Anderson, Jacksonville, Florida, United States, 32207

LOCATION TWO

PRINCIPAL INVESTIGATOR

Dr Robert Cavaliere, MD

Neuro-oncologist

Robert Cavaliere, MD, graduated from New York City Medical School. He completed his residency in Neurology and a fellowship in Neuro-oncology at the University of Virginia. Upon completing training he joined the Ohio State University Neuro-oncology Program, where he remained for 10 years until moving to Jacksonville, Florida. It is here that he directs the Brain and Spine tumor program at Baptist MD Anderson. Throughout his career, clinical research has been a priority, serving as lead investigator of many therapeutic trials for primary brain tumors. Dr. Cavaliere has served on and directed the Scientific Review Committee and IRB at Ohio State University and Baptist MD Anderson. He has also managed the Neuro-oncology clinical trial portfolios in both locations. His research focus is brain tumor therapeutics, including intracerebral administration of experimental agents.

Email: dukebrain1@dm.duke.edu

Phone: +1 919-684-5301

Duke University Hospital, Durham, North Carolina, United States, 27710

LOCATION ONE

PRINCIPAL INVESTIGATOR

Dr Annick Desjardins, MD

Professor of Neurosurgery and Neurology

Annick Desjardins, MD, FRCPC, completed her residency in Adult Neurology at the Universite de Sherbrooke, Quebec, Canada. This was followed by a two-year fellowship in Neuro-oncology at The Preston Robert Tisch Brain Tumor Center at Duke. Upon completion of her fellowship in July of 2005, she joined the Preston Robert Tisch Brain Tumor Center as faculty. Dr. Desjardins is the Director of Clinical Research at the Preston Robert Tisch Brain Tumor Center at Duke. She is also Clinical Trials Core Co-Director for the Duke Brain Tumor SPORE and P01 grants. She chairs one of the monthly DCI PRMC meetings, serves on the Faculty Advisory Committee for DCI Clinical Research and is a reviewer for the Neurosurgery CRU. She is a Fellow of the Royal College of Physicians of Canada in Adult Neurology and is certified in the subspecialty of Neuro-oncology by the United Council for Neurologic Subspecialties. Her main focus in clinical research includes the direct intracerebral administration of therapeutics, including oncolytic viruses, immunotoxins and others via convection-enhanced delivery. 

This website is intended for residents of the USA only. This site does not provide medical advice. The site, content, and services do not provide any form of medical advice or recommendations and is provided for general information purposes only. For full disclaimer, please refer to the terms and conditions of use.